Literature DB >> 548534

Prazosin determination by high-pressure liquid chromatography using fluorescence detection.

Y G Yee, P C Rubin, P Meffin.   

Abstract

A high-pressure liquid chromatographic procedure using fluorescence detection for the analysis of prazosin in whole blood and plasma is described. It employs a simple and rapid method of sample preparation. Prazosin and an internal standard are chromatographed as ion-pairs with pentane sulfonic acid. The method is sensitive and reproducible with accurate detection as low as 0.2 ng/ml in whole blood and 0.5 ng/ml in plasma with a coefficient of variation of 5.6% and 5.4% respectively. If propranolol or quinidine is present, modifications of chromatographic conditions are used which separate prazosin from these two drugs. Prazosin is stable when frozen for a long period or refrigerated for short periods.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 548534     DOI: 10.1016/s0021-9673(00)90967-1

Source DB:  PubMed          Journal:  J Chromatogr


  14 in total

1.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

Authors:  P C Rubin; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

2.  Prazosin protein binding in health and disease.

Authors:  P Rubin; T Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

3.  Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

4.  Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics.

Authors:  R Donnelly; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

5.  Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.

Authors:  C A Hamilton; J L Reid; J Vincent
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

6.  "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

Authors:  D McAreavey; L E Ramsey; L Latham; A D McLaren; A R Lorimer; J L Reid; J I Robertson; M P Robertson; R J Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14

7.  Rapid and sensitive online determination of some selective α1-blockers by flow injection analysis with micelle-enhanced fluorescence detection.

Authors:  Niveen A Mohamed; Sameh Ahmed; Sally A El Zohny
Journal:  J Fluoresc       Date:  2013-07-20       Impact factor: 2.217

8.  Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension.

Authors:  P C Rubin; L Butters; R A Low; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

9.  Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.

Authors:  P R Mills; A P Rae; D A Farah; R I Russell; A R Lorimer; D C Carter
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

10.  Prazosin disposition in young and elderly subjects.

Authors:  P C Rubin; P J Scott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.